Get Quotes

Market Menu

News Details

( As on 13/02/2019 14:56) Jagsonpal Pharma - Outcome of Board Meeting

In terms of the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, (i.e. Wednesday, the 13th Day of February, 2019) at registered office, have inter-alia, approved and taken on record the following:

1. Un-Audited Standalone Financial Results of the Company for the Quarter ended 31st December, 2018;
2. Limited Review Report for the Quarter ended 31st December, 2018;
3. Other Agenda items.

The meeting commenced at 12:00 P.M. and concluded at 02:50 P.M.

Kindly take the above on record & oblige.